These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20739468)

  • 1. Microarray analysis of iris gene expression in mice with mutations influencing pigmentation.
    Trantow CM; Cuffy TL; Fingert JH; Kuehn MH; Anderson MG
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):237-48. PubMed ID: 20739468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated oxidative membrane damage associated with genetic modifiers of Lyst-mutant phenotypes.
    Trantow CM; Hedberg-Buenz A; Iwashita S; Moore SA; Anderson MG
    PLoS Genet; 2010 Jul; 6(7):e1001008. PubMed ID: 20617205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyst mutation in mice recapitulates iris defects of human exfoliation syndrome.
    Trantow CM; Mao M; Petersen GE; Alward EM; Alward WL; Fingert JH; Anderson MG
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1205-14. PubMed ID: 19029039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype associations in Danish patients with ocular and oculocutaneous albinism.
    Kessel L; Kjer B; Lei U; Duno M; Grønskov K
    Ophthalmic Genet; 2021 Jun; 42(3):230-238. PubMed ID: 33612058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and clinical characterization of albinism in a large cohort of Italian patients.
    Gargiulo A; Testa F; Rossi S; Di Iorio V; Fecarotta S; de Berardinis T; Iovine A; Magli A; Signorini S; Fazzi E; Galantuomo MS; Fossarello M; Montefusco S; Ciccodicola A; Neri A; Macaluso C; Simonelli F; Surace EM
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1281-9. PubMed ID: 20861488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic modulation of the iris transillumination defect: a systems genetics analysis using the expanded family of BXD glaucoma strains.
    Swaminathan S; Lu H; Williams RW; Lu L; Jablonski MM
    Pigment Cell Melanoma Res; 2013 Jul; 26(4):487-98. PubMed ID: 23582180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3.
    Onojafe IF; Megan LH; Melch MG; Aderemi JO; Alur RP; Abu-Asab MS; Chan CC; Bernardini IM; Albert JS; Cogliati T; Adams DR; Brooks BP
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4945-4952. PubMed ID: 30347088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex interactions of Tyrp1 in the eye.
    Lu H; Li L; Watson ER; Williams RW; Geisert EE; Jablonski MM; Lu L
    Mol Vis; 2011; 17():2455-68. PubMed ID: 21976956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albinism and the associated ocular defects.
    Oetting WS; Summers CG; King RA
    Metab Pediatr Syst Ophthalmol (1985); 1994; 17(1-4):5-9. PubMed ID: 8719278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression pattern of the ocular albinism type 1 (Oa1) gene in the murine retinal pigment epithelium.
    Surace EM; Angeletti B; Ballabio A; Marigo V
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4333-7. PubMed ID: 11095635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients.
    Hutton SM; Spritz RA
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):868-72. PubMed ID: 18326704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico analysis of miRNA-mediated gene regulation in OCA and OA genes.
    Kamaraj B; Gopalakrishnan C; Purohit R
    Cell Biochem Biophys; 2014 Dec; 70(3):1923-32. PubMed ID: 25060099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iris transillumination defect and its gene modulators do not correlate with intraocular pressure in the BXD family of mice.
    Lu H; Lu L; Williams RW; Jablonski MM
    Mol Vis; 2016; 22():224-33. PubMed ID: 27011731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmic features of minimal pigment oculocutaneous albinism.
    Summers CG; King RA
    Ophthalmology; 1994 May; 101(5):906-14. PubMed ID: 8190479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel TYR and TYRP1 mutations in oculocutaneous albinism.
    Forshew T; Khaliq S; Tee L; Smith U; Johnson CA; Mehdi SQ; Maher ER
    Clin Genet; 2005 Aug; 68(2):182-4. PubMed ID: 15996218
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
    Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
    N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice.
    Anderson MG; Smith RS; Hawes NL; Zabaleta A; Chang B; Wiggs JL; John SW
    Nat Genet; 2002 Jan; 30(1):81-5. PubMed ID: 11743578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
    Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
    Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of ocular hypopigmentation in Rab38cht/cht mice.
    Brooks BP; Larson DM; Chan CC; Kjellstrom S; Smith RS; Crawford MA; Lamoreux L; Huizing M; Hess R; Jiao X; Hejtmancik JF; Maminishkis A; John SW; Bush R; Pavan WJ
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3905-13. PubMed ID: 17724166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.